JPRN-UMIN000009721招募中1 期
Phase I trial of safety of carbon-ion radiotherapy for primary malignant bone and soft tissue tumor in the childhood (GUNMA1102) - Carbon-ion radiotherapy for primary malignant bone and soft tissue tumor in the childhood (GUNMA1102)
Gunma University Heavy-ion Medical Center0 个研究点目标入组 6 人开始时间: 2013年1月8日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- 入组人数
- 6
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 6years-old 至 16years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Obvious intravascular embolus in radiographics 2) Artifact affecting dose caliculation 3) Obivious tumor invasion to bowels 4) Past history of chemotherapy within 4 weeks before treatment 5) Uncontrolled infectious disease 6) Past history of irradiation to the target 7) Uncontrolled severe complication 8) Active double cancers 9) Other medical or psychological unsuitable reasons
研究者
相似试验
招募中
不适用
A Study to Evaluate Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of Tripegfilgrastim in Pediatric Solid Tumor/Lymphoma PatientsNeoplasmsKCT0002244Dong-A ST32
未知
1 期
A Phase I clinical trial to investigate the safety and tolerability of NK105 when co-administered with carboplatin once per week to Japanese patients with advanced solid cancers.Advanced solid cancersJPRN-jRCT2080223202ippon Kayaku Co., Ltd.18
已完成
1 期
A first-in-human safety study of the novel adrenal PET tracer [18F]CETOPrimary aldosteronismNutritional, Metabolic, EndocrinePrimary hyperaldosteronismISRCTN16159564Cambridge University Hospitals NHS Foundation Trust11
已完成
不适用
Phase 1 clinical trial on the safety and efficacy of the negative-balance isolated pelvic perfusion (NIPP) for pelvic malignancy (uterine cervical cancer)terine cervical cancerJPRN-UMIN000025351ippon medical school hospital27
已完成
1 期
A Phase I clinical trial to evaluate the safety and pharmacokinetics of SHR0302 base ointment at single dose and multiple dose in healthy adult subjectsAtopic dermatitisSkin - Dermatological conditionsACTRN12619001443189Reistone Biopharma Co., Ltd.32